EUVIMEDEUVIMED entdecken
Crossref

Pulmonary hypertension in patients with Noonan syndrome

Julien Grynblat iD, Mathieu Farges, Pascal Magro iD, Laurent Savale iD, Maria-Rosa Ghigna iD, Julia Tagmouti, Xavier Jais iD, Athénaïs Boucly iD, Marilyne Levy iD, Fabrice Antigny iD, Olivier Meyrignac iD, Stanislas Lyonnet iD und 8 weitere

European Respiratory Journal · 2026

DOI: 10.1183/13993003.01796-2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Respiratory Journal, 2026. Verfasst von Julien Grynblat und 19 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris-Saclay, Inserm UMR_S 999 (HPPIT), Department of Respiratory and Intensive Care Medicine (FHU André Cournand, ERN-LUNG), Hôpital Bicê…. Hauptthemen laut MEDLINE: Noonan Syndrome, Hypertension, Pulmonary. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Noonan syndrome is a RASopathy inherited in an autosomal dominant manner, mainly caused by gain-of-function variants activating the RAS/mitogen-activated protein kinase signalling pathway. Pulmonary hypertension (PH) may occur in Noonan syndrome, but its mechanisms, clinical characteristics and outcomes remain poorly defined.

Methods

We analysed data from the French PH Network to characterise the phenotype of Noonan syndrome patients who develop PH, and conducted a systematic analysis of the literature.

Results

Seven patients were identified from the French PH Network (male/female ratio 1.3:1), with a median (range) age at PH diagnosis of 9 (5–21) years. Genetic analysis revealed five pathogenic variants in PTPN11 and one in SHOC2 . Associated features included facial dysmorphism, growth retardation, atrial septal defect and pulmonary valve stenosis. Haemodynamics showed severe pre-capillary PH without acute vasodilator response: mean pulmonary arterial pressure 55 (40–78) mmHg, cardiac output 3.95 (3.12–4.95) L·min −1 and pulmonary vascular resistance 13 (10–15.3) WU. Computed tomography of the chest identified perivascular ground-glass opacities, mediastinal infiltration, dilated bronchial arteries, distal pulmonary vascular tortuosity and possible arteriovenous shunts. Five patients were treated with drugs approved for pulmonary arterial hypertension. Three patients died and one underwent lung transplantation. Explanted lungs revealed plexiform lesions associated with diffuse lymphangiectasia. 12 additional cases from the literature included seven with pre-capillary PH, four with post-capillary PH due to cardiomyopathy and one without right heart catheterisation.

Conclusion

Pre-capillary and post-capillary PH may complicate the course of Noonan syndrome, potentially in association with congenital heart defects and multisystem manifestations. Further studies are needed to better delineate the phenotype of PH in patients with Noonan syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Noonan SyndromeHypertension, PulmonaryHumansFemaleAdolescentChildProtein Tyrosine Phosphatase, Non-Receptor Type 11MalePhenotypeChild, PreschoolYoung AdultTomography, X-Ray ComputedFranceHemodynamicsMutation

Substanzen

Protein Tyrosine Phosphatase, Non-Receptor Type 11PTPN11 protein, human

Autor:innen und Institutionen

  • Université Paris-Saclay, Inserm UMR_S 999 (HPPIT), Department of Respiratory and Intensive Care Medicine (FHU André Cournand, ERN-LUNG), Hôpital Bicêtre (AP-HP), Le Kremlin-Bicêtre, France.
  • M3C-Necker, Hôpital Necker-Enfants Malades, AP-HP, Université Paris Cité, Cardiologie Congénitale et Pédiatrique, Paris, France.
  • J. Grynblat and M. Farges contributed equally.
  • Centre Hospitalier Régional Universitaire de Tours, Service de Pneumologie, Hôpital Bretonneau, Tours, France.
  • Biopathology Department, Gustave Roussy Cancer Campus, Villejuif, France.
  • Service de Radiologie Diagnostique et Interventionnelle Adulte, Biomaps - Laboratoire d'Imagerie Multimodale - CEA-INSERM-CNRS, Hôpital de Bicêtre, DMU 14 Smart Imaging, AP-HP, Le Kremlin-Bicêtre, France.

ORCID-Profile: Julien Grynblat, Pascal Magro, Laurent Savale, Maria-Rosa Ghigna, Xavier Jais, Athénaïs Boucly, Marilyne Levy, Fabrice Antigny, Olivier Meyrignac, Stanislas Lyonnet, Helene Cavé, Romain Nicolle, Sylvain Marchand-Adam, Olivier Sitbon, Florence Coulet, Marc Humbert, Damien Bonnet, David Montani

Zitieren

APA

Grynblat, J., Farges, M., Magro, P., Savale, L., Ghigna, M. R., Tagmouti, J., Jais, X., Boucly, A., Levy, M., Antigny, F., Meyrignac, O., Lyonnet, S., Cavé, H., Nicolle, R., Marchand-Adam, S., Sitbon, O., Coulet, F., Humbert, M., Bonnet, D., & Montani, D. (2026). Pulmonary hypertension in patients with Noonan syndrome. European Respiratory Journal. https://doi.org/10.1183/13993003.01796-2025

Vancouver

Grynblat J, Farges M, Magro P, Savale L, Ghigna MR, Tagmouti J, et al. Pulmonary hypertension in patients with Noonan syndrome. European Respiratory Journal. 2026. doi:10.1183/13993003.01796-2025

BibTeX
@article{Grynblat2026,
  author = {Grynblat, Julien and Farges, Mathieu and Magro, Pascal and Savale, Laurent and Ghigna, Maria-Rosa and Tagmouti, Julia and Jais, Xavier and Boucly, Athénaïs and Levy, Marilyne and Antigny, Fabrice and Meyrignac, Olivier and Lyonnet, Stanislas and Cavé, Helene and Nicolle, Romain and Marchand-Adam, Sylvain and Sitbon, Olivier and Coulet, Florence and Humbert, Marc and Bonnet, Damien and Montani, David},
  title = {Pulmonary hypertension in patients with Noonan syndrome},
  journal = {European Respiratory Journal},
  year = {2026},
  doi = {10.1183/13993003.01796-2025}
}
Kostenlos starten →